1. Home
  2. QMCO vs SABS Comparison

QMCO vs SABS Comparison

Compare QMCO & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QMCO
  • SABS
  • Stock Information
  • Founded
  • QMCO 1980
  • SABS 2014
  • Country
  • QMCO United States
  • SABS United States
  • Employees
  • QMCO N/A
  • SABS N/A
  • Industry
  • QMCO Electronic Components
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • QMCO Technology
  • SABS Health Care
  • Exchange
  • QMCO Nasdaq
  • SABS Nasdaq
  • Market Cap
  • QMCO 25.4M
  • SABS 23.9M
  • IPO Year
  • QMCO N/A
  • SABS N/A
  • Fundamental
  • Price
  • QMCO $3.31
  • SABS $3.10
  • Analyst Decision
  • QMCO Hold
  • SABS Strong Buy
  • Analyst Count
  • QMCO 2
  • SABS 5
  • Target Price
  • QMCO $5.00
  • SABS $12.40
  • AVG Volume (30 Days)
  • QMCO 75.9K
  • SABS 78.1K
  • Earning Date
  • QMCO 11-13-2024
  • SABS 11-06-2024
  • Dividend Yield
  • QMCO N/A
  • SABS N/A
  • EPS Growth
  • QMCO N/A
  • SABS N/A
  • EPS
  • QMCO N/A
  • SABS N/A
  • Revenue
  • QMCO $285,238,000.00
  • SABS $1,512,723.00
  • Revenue This Year
  • QMCO N/A
  • SABS N/A
  • Revenue Next Year
  • QMCO $0.11
  • SABS N/A
  • P/E Ratio
  • QMCO N/A
  • SABS N/A
  • Revenue Growth
  • QMCO N/A
  • SABS N/A
  • 52 Week Low
  • QMCO $2.22
  • SABS $2.16
  • 52 Week High
  • QMCO $18.00
  • SABS $9.72
  • Technical
  • Relative Strength Index (RSI)
  • QMCO 45.64
  • SABS 48.28
  • Support Level
  • QMCO $4.22
  • SABS $3.17
  • Resistance Level
  • QMCO $4.99
  • SABS $3.74
  • Average True Range (ATR)
  • QMCO 0.64
  • SABS 0.48
  • MACD
  • QMCO -0.07
  • SABS -0.04
  • Stochastic Oscillator
  • QMCO 7.84
  • SABS 17.53

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: